Showing 181-190 of 797 results for "".
Completion of the Etiologic Workup: Roles for Advanced Cardiac Imaging and Long-Term Cardiac Monitoring
https://practicalneurology.com/diseases-diagnoses/stroke/completion-of-the-etiologic-workup-roles-for-advanced-cardiac-imaging-and-long-term-cardiac-monitoring/31964/Proper care of people with cryptogenic stroke requires a tailored approach in the search for cardioembolic sources.MS Minute: Multiple Sclerosis & the Gut Microbiome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-multiple-sclerosis-the-gut-microbiome/31927/The gut microbiome and its relationship with MS is an exciting and active area of research with much promise and much to be elucidated.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Adult-Onset Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/adult-onset-cerebellar-ataxias/31934/Adult-onset cerebellar ataxias have overlapping phenotypes and diverse causes; tiered testing is a useful diagnostic framework.Update on Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-on-refractory-status-epilepticus/30758/The first priority for the consulting neurologist is confirming the diagnosis. Treating any underlying disease does far more to improve outcome than mere suppression of seizures. Treatment options exist for prolonged SE, but clinicians must be realistic with families.Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31360/In the rapidly evolving healthcare landscape, prioritizing patient-centered care remains crucial, particularly in neurology practices. Increasing pressures from payers have compelled providers to see more patients in less time, often shifting the focus from individual patient needs to systemic effic
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31223/CPT 2007 Updates Impact Neurology PracticesThe 2007 update to the Current Procedural Terminology (CPT) manual introduces several significant changes pertinent to neurology practices, as outlined by Mary H. McDermott in Practical Neurology. While the overall modifications affecting neurology are limi